SOP for Adverse Event Monitoring and Reporting
Protocol for Surveillance and Documentation of Adverse Events in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the systematic monitoring, documentation, assessment, and reporting of adverse events (AEs) occurring during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel…
Read More “SOP for Adverse Event Monitoring and Reporting” »